Interval Cytoreductive Surgery Following Neoadjuvant Chemotherapy Improves Advanced Ovarian Cancer Outcomes

Neoadjuvant chemotherapy followed by interval cytoreductive surgery significantly improves survival rates in patients with advanced ovarian cancer compared with chemotherapy alone.